(lp0
S'Risk Malaise Alert in Option Market: Cambrex Corporation Implied Price Swing ... CML News - 11 hours ago Before we dive into any analysis we simply note that Cambrex Corporation  risk is actually priced pretty low by the option market as of right now.'
p1
aS'Cambrex Corporation: Exciting Time Ahead For This Biotech Company Seeking Alpha - Mar 24, 2016 Several months ago, I wrote a research article on Cambrex . The company has been growing impressively and just had a record year while the stock is up about 90% since 2015.'
p2
aS"Claes Glassell Appointed to the Board of Directors of Cambrex Corporation GlobeNewswire  - Mar 16, 2016 EAST RUTHERFORD, N.J., March 16, 2016  -- Cambrex Corporation   announced today that on March 14, 2016, Claes Glassell was appointed to the Company's Board of Directors for a term expiring on the date&nbsp;..."
p3
aS'Cambrex: A Pure Growth Play Seeking Alpha - Feb 15, 2017 Cambrex provides products and services for the development and commercialization of new and generic therapeutics. They operate in North America, Europe, and Asia.'
p4
aS'Cambrex Corporation Completes Expansion at Iowa Facility Pharmaceutical Technology Magazine   - Jul 19, 2016 Cambrex Corporation announced on July 12, 2016 the completion and validation of a $50-million production and warehousing expansion at its cGMP Charles City, Iowa site.'
p5
aS'Decision Time: Cambrex Corporation  Stock Technicals Hit Inflection ... CML News - 20 hours ago Decision Time: Cambrex Corporation  now sits in the perhaps the most difficult technical position -- the stock has no urgency in its direction and that has left it at an inflection point.'
p6
aS'Examining the Numbers on Shares of Cambrex Corporation  Rives Journal - 11 hours ago Cambrex Corporation  currently has a Gross Margin  ratio of 0.333274. Robert Novy-Marx has provided investors with insights on finding high-quality value stocks.'
p7
aS'Cambrex: Overblown Concerns Present Attractive Entry Opportunity Into Growing ... Seeking Alpha - Oct 3, 2016 The risk of a Gilead-driven downturn is already priced in and offers an attractive buying opportunity. Active Pharmaceutical Ingredients  volumes and outsourcing will increase, drug companies continue to favor high-quality US and European&nbsp;...'
p8
aS'Cambrex Corp.  to Acquire Privately-Held PharmaCore for ~$25M StreetInsider.com - Sep 26, 2016 Cambrex Corporation  agreed to acquire PharmaCore Inc., a privately-owned company specializing in developing, manufacturing and scaling up small molecule APIs for clinical phase projects, for approximately $25 million.Cambrex bolstering API services through $25m PharmaCore acquisition - In-PharmaTechnologist.com'
p9
aS'Cambrex Corporation  added to 43 new portfolios Post Analyst - Mar 27, 2017 Cambrex Corporation  reached 31.72% versus a 1-year low price of $38.3. The stock was last seen -0.88% lower, reaching at $50.45 on Mar. 24.Broker Outlook For The Week Ahead Cambrex Corporation  - Fiscal StandardCambrex  Touches $50.45 Formed H&amp;S, Netsol Technologies  Sentiment ... - Wolcott Daily'
p10
a.